<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The concentrations of the <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> metabolites, <z:mp ids='MP_0002515'>PGD2</z:mp>, PGF2 alpha and 6-keto-<z:chebi fb="0" ids="28852">PGF1 alpha</z:chebi>, were measured in the cerebral hemispheres of gerbils subjected to unilateral carotid occlusion </plain></SENT>
<SENT sid="1" pm="."><plain>Approximately 37 percent of the animals with occlusion had symptoms of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In those animals <z:mp ids='MP_0002515'>PGD2</z:mp> and PGF2 alpha levels were elevated in both hemispheres </plain></SENT>
<SENT sid="3" pm="."><plain>The levels of 6-keto-<z:chebi fb="0" ids="28852">PGF1 alpha</z:chebi> increased only slightly </plain></SENT>
<SENT sid="4" pm="."><plain>There was no change of <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> levels in asymptomatic animals </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="49662">Indomethacin</z:chebi> inhibited the increase in the levels of these <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> metabolites but did not alter <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e> as judged by a decrease in specific gravity after 6 hours occlusion </plain></SENT>
</text></document>